Explore our high-performance natural chemical structures and synthetic precursors optimized for formulation stability and enhanced bioavailability.
Common Statins (HMG-CoA reductase inhibitors) such as Atorvastatin, Rosuvastatin, and Simvastatin represent the gold standard in the management of hypercholesterolemia and cardiovascular disease risks. Today, the global pharmaceutical landscape is seeking dynamic optimizations in the synthesis, production, and adjuvant therapies surrounding cardiovascular drugs. Advanced factories and chemical manufacturers are focusing heavily on biochemical precursors, including high-purity bile acids and plant-derived cardiovascular metabolic active compounds.
“As lipid management targets become more stringent internationally, the therapeutic synergy between traditional HMG-CoA reductase inhibitors and natural lipid-regulating compounds continues to redefine research paradigms.”
By leveraging natural derivatives such as Cholic Acid, Deoxycholic Acid, and Taurochenodeoxycholic Acid, modern pharmaceutical researchers are resolving complex solubility and bioavailability barriers. For example, bile acids serve as biological surfactant systems that facilitate lipid transport, while botanical flavonoids like Rutin and Quercetin target oxidative stress within vascular walls, providing dual protection against LDL cholesterol oxidation.
Navigating complex international supply chains and quality management controls in high-performance pharmaceutical manufacturing.
Bile acid chemistry is vital for structural analogues in target therapeutic areas. Factories utilize highly integrated cholic and deoxycholic acid platforms as key starting materials for cardiovascular and metabolic drug delivery systems.
Global supply networks demand strict alignment with USP, EP, and ChP pharmacopeias. Active pharmaceutical ingredients (APIs) and plant-derived therapeutics must ensure low endotoxin and heavy metal profiles to meet stringent FDA and EMEA requirements.
Industrial trends emphasize chemical synthesis reduction, prioritizing enzymatic transformation and mild organic extractions. Chengdu Chenlv Herb utilizes clean biological processes to lower the carbon footprint of critical chemical pipelines.
Innovative Natural Ingredient Solutions for Global Healthcare and Pharmaceutical Formulations
Chengdu Chenlv Herb Co., Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Established In
Choose Chenlv Herb for products that deliver beyond expectations, supporting your manufacturing workflows from development to global supply.
Creative designs and advanced synthesis routes that elevate your pharmaceutical formulation and market brand.
Streamlined extraction operations, optimization, and eco-friendly packaging aligned with modern environmental guidelines.
End-to-end cosmetic and active ingredient packaging solutions with strict environmental tracking.
Fast processing timelines and direct factory communications to reliably meet strict customer launch timelines.
A dedicated pharmaceutical audit team supporting analytical parameters and process verification at every step.
Years of proven industrial expertise ensuring precision and compliance across complex organic chemical profiles.
Navigating global regulatory landscapes requires a manufacturer with deep validation and certification support. Chenlv Herb ensures that our entire supply pipeline complies with international laws, reducing audit risks for our global clients. Whether you are sourcing precursors for statin formulations or botanical complexes, our processes meet strict quality frameworks.
Our localized services provide seamless import assistance, custom packaging solutions, and local logistics coordination. We maintain complete traceability for every batch of Cholic Acid, Quercetin, or Rutin, including comprehensive documentation such as Certificates of Analysis (COA), HPLC chromatograms, and safety data sheets.
Our quality management systems are certified under ISO9001, ISO22000, HALAL, KOSHER, and meet FDA registration criteria, assuring clients of safety across medical and dietary fields.
Our active ingredients are integrated across critical target markets, delivering verified bio-potency and stability.
Driven by the concept of "homology of medicine and food", plant extracts have become core raw materials for natural health supplements due to their organic profile.
Read More →
From ancient herbal formulas to modern innovative pharmaceuticals, active plant components hold a primary role in developing targeted therapeutic formulations.
Read More →
Meeting consumer demand for clean beauty, plant extracts provide skin-friendly, bio-compatible alternatives for antioxidant protection and skin regeneration.
Read More →
Botanical extracts offer natural solutions for animal feed formulations, improving immunity, gut health, and feed conversion efficiency.
Read More →Looking ahead, the development of cardiovascular therapeutics will focus on enhancing delivery mechanisms and establishing synergistic chemical designs. Synthesized statin structures are increasingly combined with high-purity bile acid carriers to optimize absorption kinetics and decrease adverse effects on liver enzymes. Simultaneously, biocatalytic routes are replacing high-energy chemical steps in precursor manufacturing.
Chenlv Herb is investing in green chemistry and automated extraction platforms. Our technical roadmap aims to increase the yield of active bio-flavonoids like Apigenin and Fisetin, while reducing energy use. By integrating synthetic biology with plant-cell cultivation, we ensure a sustainable supply of vital organic intermediates for cardiovascular drug developers worldwide.
Chenlv Herb provides one-stop contract manufacturing and optimization services for custom purity formulations.
01
We consult with your engineering and formulation teams to define product specs and purity targets.
02
We provide a competitive pricing proposal based on target volumes, packaging, and regulatory needs.
03
We sign a detailed contract outlining quality guidelines, yield requirements, and logistics timelines.
04
We prepare trial batches and lab samples to confirm physical properties and analytical assays.
05
Following sample approval, our factory schedules production, utilizing GMP-aligned protocols.
06
Each production batch undergoes rigorous testing, verified by COAs and QA release reviews.
07
We dispatch shipments globally via tracked freight networks, managing custom export clearance.
Our facility operates under rigorous international quality frameworks, ensuring compliance for global exports.
Find answers to technical and regulatory questions regarding our active pharmaceutical ingredients and plant precursors.
Stay updated on our R&D developments, conference schedules, and global pharmaceutical supply achievements.
Analyzing the supply and demand dynamics of Citrus aurantium as raw material prices shift, affecting downstream extract markets.
Join us at CPHI China 2025 in Shanghai to discuss natural APIs and cardiovascular formulation solutions.
Collaborating on bio-precursors and standardized plant compounds at China’s premier API trade venue.
Our complete product range of natural acids and flavonoid extracts, manufactured in compliance with international quality standards.
